Bristol-Myers Squibb Company
Cyclic dinucleotides as anticancer agents
Last updated:
Abstract:
The present invention is directed to compounds of the formula ##STR00001## wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
Status:
Grant
Type:
Utility
Filling date:
16 Oct 2018
Issue date:
30 Aug 2022